Immunogen reported $306.47M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Abbvie ABBV:US $ 16283M 875M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Amgen AMGN:US $ 916M 5784M
Astellas Pharma 4503:JP Y 1460308M 5983M
AstraZeneca AZN:LN 36340M 2928M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Eli Lilly And LLY:US $ 9330.8M 351.6M
Emergent Biosolutions EBS:US $ 1575.3M 43.7M
Exelixis EXEL:US $ 2293.85M 83.24M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 73.84M 33.51M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Macrogenics MGNX:US $ 178.21M 61.4M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Novartis NVS:US $ 61540M 6115M
Pfizer PFE:US $ 82424M 5224M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Seattle Genetics SGEN:US $ 2998.47M 66.67M